Why the study?
The study was conducted to evaluate the efficacy, safety, long-term outcomes, and renal impact of a renoprotective non-contrast, transoesophageal echocardiography-guided transapical TAVR strategy using a balloon-expandable prosthesis.
Is non-contrast, transoesophageal echocardiography-guided transapical TAVR safe and effective for preserving renal function in patients undergoing TAVR?
Population
200 consecutive patients undergoing transapical TAVR
Comparison
Non-contrast transoesophageal echocardiography-guided TA TAVR with a balloon-expandable prosthesis
Design
Observational cohort study
Follow-up
Mean 48.5 ± 39.9 months
Authors
Loading...
Non-contrast TEE-guided TA TAVR may preserve renal function in high-risk patients; leaves open superiority versus contrast-based strategies.
Is non-contrast, transoesophageal echocardiography-guided transapical TAVR safe and effective for preserving renal function in patients undergoing TAVR?
Non-contrast TEE-guided transapical TAVR is a safe and reproducible strategy that maintains renal function and mitigates the incidence of acute kidney injury.
Mosquera et al. (2021) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: